|
gptkb:Ruxolitinib
|
live vaccines
|
|
gptkb:lorlatinib
|
CYP3 A4 inhibitors
|
|
gptkb:ziconotide
|
CNS depressants
|
|
gptkb:Nexavar
|
gptkb:warfarin
|
|
gptkb:Nurofen_Plus
|
other opioids
|
|
gptkb:Breztri
|
corticosteroids
|
|
gptkb:Retin-A
|
avoid using with harsh skin products
|
|
gptkb:Gefitinib
|
H2-receptor antagonists
|
|
gptkb:Sporanox
|
CYP3 A4 inhibitors
|
|
gptkb:Biosimilar_to_Adalimumab
|
similar to Adalimumab
|
|
gptkb:Golodirsen
|
none reported
|
|
gptkb:Paxlovid
|
CYP3 A4 inhibitors
|
|
gptkb:USCGC_William_Trump
|
gptkb:Yes
|
|
gptkb:LOXO-292
|
CYP3 A4 inducers
|
|
gptkb:Tezacaftor
|
CYP3 A inhibitors
|
|
gptkb:artesunate-amodiaquine
|
may increase liver toxicity
|
|
gptkb:Gefitinib
|
antacids
|
|
gptkb:Zyban
|
antipsychotics
|
|
gptkb:Combivent_Respimat
|
beta-blockers
|
|
gptkb:Cymbalta
|
gptkb:warfarin
|